Denali Advisors LLC Eagle Pharmaceuticals, Inc. Transaction History

Denali Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 19, 2024	SELL	$4.63 - $15.21 $26,391 - $86,697	-5,700 Reduced 17.65%	26,600 $139,000
Q3 2023 Oct 19, 2023	BUY	$15.21 - $22.88 $168,831 - $253,968	11,100 Added 52.36%	32,300 $509,000
Q2 2023 Jul 18, 2023	BUY	$17.74 - $31.87 $340,607 - $611,904	19,200 Added 960.0%	21,200 $412,000
Q4 2022 Feb 09, 2023	BUY	$24.98 - $39.77 $49,960 - $79,540	2,000 New	2,000 $58,000

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Denali Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Denali Advisors LLC with notifications on news.